Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$228.26 - $319.04 $189,455 - $264,803
-830 Reduced 19.62%
3,400 $1.08 Billion
Q1 2024

May 16, 2024

BUY
$210.76 - $249.51 $891,514 - $1.06 Million
4,230 New
4,230 $972 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track La Banque Postale Asset Management Sa Portfolio

Follow La Banque Postale Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of La Banque Postale Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on La Banque Postale Asset Management Sa with notifications on news.